Bipolar Research Study Using MR Imaging

Status Completed

Clinical Trial Summary

In this proposal, the investigators will focus on subcortical gray and white matter structures commonly found to be abnormal in schizophrenia. Thus, the investigators will evaluate the volume and shape of the hippocampus, thalamus and basal ganglia, as well as measures of structural integrity of the corpus callosum and its various subregions.

Clinical Trial Description

There are relatively few studies evaluating brain structure in bipolar disorder (BD), the results of which have been largely inconsistent, both in terms of what abnormalities are present in BD and whether they show any similar abnormalities to those found in schizophrenia. One possibility that might explain the varying degree of reported similarity in structural findings in schizophrenia and BD is that there might be effects of BPD diagnostic subtype associated with brain structure. One viewpoint that contrasts schizophrenia and BD considers psychotic (PBD) to differ from non-psychotic (NPBD) subtypes in terms of shared pathophysiology with schizophrenia. PBD has been reported as being of special interest, as it shares symptomatic overlap with schizophrenia, "runs in families", shares a chromosomal linkage to the 13q13-32 and 22q12 with schizophrenia, shows similar increases in dopamine receptor Bmax induced by [c-11] N-methylspiperone positron emission tomography and similar working memory impairments as in schizophrenia. If PBP and NPBP are associated with different forms of brain pathology, then merging the two entities into a single "bipolar group" might obscure relevant anatomic differences if these occur primarily in only one group. In this proposal, the investigators will focus on subcortical gray and white matter structures commonly found to be abnormal in schizophrenia. Thus, the investigators will evaluate the volume and shape of the hippocampus, thalamus and basal ganglia, as well as measures of structural integrity of the corpus callosum and its various subregions. ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02083978
Study type	Observational
Source	Washington University Early Recognition Center
Contact
Status	Completed
Phase	N/A
Start date	January 2010
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03275714` - Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder	N/A
Completed	`NCT03249857` - Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.	N/A
Completed	`NCT01722344` - Improving Work Outcome for People With Severe Mental Illness	N/A
Completed	`NCT01431092` - Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia	Phase 4
Completed	`NCT01315028` - Bipolar Intervention Study: Cognitive Interpersonal Therapy	N/A
Terminated	`NCT00805493` - Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder	Phase 2
Completed	`NCT00436020` - rTMS in the Treatment of Bipolar Depression	N/A
Withdrawn	`NCT00397605` - Cannabinoids in Bipolar Affective Disorder	N/A
Recruiting	`NCT05860101` - Compassion-Focused Therapy for Distressing Mood Swings: A Case Series	N/A
Recruiting	`NCT06176456` - Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia	N/A
Terminated	`NCT03310593` - Cannabidiol as an Adjunctive Treatment for Bipolar Depression	Phase 2/Phase 3
Recruiting	`NCT05406414` - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems	N/A
Completed	`NCT02773108` - Somatic Comorbidities in Psychiatric Patients
Recruiting	`NCT00474357` - Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy	N/A
Withdrawn	`NCT00327756` - Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	Phase 2
Completed	`NCT02453217` - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial	N/A
Completed	`NCT05683431` - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)	N/A
Not yet recruiting	`NCT05915312` - Exosome for Early Diagnosis of Bipolar Affective Disorder
Completed	`NCT00186758` - Transcranial Magnetic Stimulation in Bipolar Depression	Phase 4
Completed	`NCT00683709` - Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.